MTND1P11: A Drug Target / Disease Biomarker (G100873212)

Target Name: MTND1P11

NCBI ID: G100873212

MTND1P11

Other Name(s): MT-ND1 pseudogene 11

MTND1P11: A Drug Target / Disease Biomarker

MTND1P11 is a protein that is expressed in the brain and is known for its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. The protein is a key component of the neurotransmitter neurotransmitter and is involved in the transmission of signals in the brain.

MTND1P11 has been identified as a potential drug target for several reasons. Firstly, the protein is over-expressed in the brain and has been shown to contribute to the development of neurodegenerative diseases. Secondly, the protein has been shown to interact with several other proteins, including the protein target of rapamycin, which is a drug used to prevent the development of certain types of cancer. This suggests that MTND1P11 may be a good candidate for a drug that targets the interaction between the protein and the target of rapamycin.

Furthermore, MTND1P11 has been shown to play a role in the regulation of the blood-brain barrier, which is the barrier that separates the brain from the rest of the body. The blood-brain barrier is important for the safe delivery of drugs to the brain and is thought to be a potential drug delivery barrier for certain types of drugs. The fact that MTND1P11 is involved in the regulation of the blood-brain barrier suggests that it may be a good candidate for a drug that targets the blood-brain barrier.

In addition to its potential as a drug target, MTND1P11 has also been shown to be involved in the regulation of several other biological processes, including cell signaling, cell migration, and neurotransmitter signaling. This suggests that the protein may be a good candidate for a drug that targets one or more of these processes.

Overall, MTND1P11 is a protein that has been shown to be involved in the development and progression of neurodegenerative diseases. Its over-expression in the brain and interaction with the protein target of rapamycin suggest that it may be a good candidate for a drug that targets the interaction between the protein and the target of rapamycin. Furthermore, the protein's role in the regulation of the blood-brain barrier suggests that it may be a good candidate for a drug that targets the blood-brain barrier. Further research is needed to confirm these findings and determine the full potential of MTND1P11 as a drug target.

Protein Name: MT-ND1 Pseudogene 11

The "MTND1P11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND1P11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets